Recently, Dai et al. found that circRNA-MYLK (hsa_circ_0141940) is significantly up-regulated in prostate cancer cell lines (LNCAP, DU145, PC-3 and PC-3MIE8) in comparison to normal prostate cell lines (WPMY-1). This evidence concerns the gene MYLK and prostate cancer.